找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Imaging Tumor Response to Therapy; Massimo Aglietta,Daniele Regge Book 2012 Springer-Verlag Italia Srl 2012 Assessment of Response.Functio

[復(fù)制鏈接]
樓主: PLY
31#
發(fā)表于 2025-3-27 00:59:58 | 只看該作者
http://image.papertrans.cn/i/image/461693.jpg
32#
發(fā)表于 2025-3-27 02:05:54 | 只看該作者
Response to Treatment: The Role of Imagingsses for some forms of cancer—resulting in a 1% annual decline in mortality from all cancers in the USA since 1990—each year, about 7 million people worldwide and 600,000 in the USA continue to die from this disease [1].
33#
發(fā)表于 2025-3-27 08:12:10 | 只看該作者
Surrogate Endpoints of Clinical Benefit and, of course, a high priority for patients and society. Similar to the HIV/AIDS community, there have been numerous efforts to accelerate approvals of new drugs but also to shorten the times required in their development and marketing, with positive as well as negative consequences.
34#
發(fā)表于 2025-3-27 11:39:13 | 只看該作者
Renal Canceross, pyrexia, neuromyopathy, anemia, polycythemia, amyloidosis, elevated erythrocyte sedimentation rate, and abnormal liver function) are found in approximately 20–30% of patients with RCC and about 20–30% of all RCC patients have metastatic disease.
35#
發(fā)表于 2025-3-27 16:00:52 | 只看該作者
Hepatocellular Carcinomaiated with liver cirrhosis and chronic infection/chronic hepatitis from viral B and C hepatitis but toxic/metabolic diseases (alcohol abuse, hemochromatosis, and nonalcoholic steatohepatitis associated with obesity and diabetes) seem to be closely linked to a higher risk of developing HCC [3–5].
36#
發(fā)表于 2025-3-27 18:27:44 | 只看該作者
37#
發(fā)表于 2025-3-28 00:04:23 | 只看該作者
Book 2012 criteria in solid tumors) have provided means to objectively measure tumor response in clinical trials with imaging. These guidelines have been rapidly adopted in clinical practice to monitor patient treatment and for therapy planning. However, relying only on anatomical information is not always s
38#
發(fā)表于 2025-3-28 05:08:04 | 只看該作者
39#
發(fā)表于 2025-3-28 06:20:23 | 只看該作者
Pancreatic Cancerine therapy and as the reference treatment arm for clinical trials in this patient population [2, 3]. However, its anti-tumoral activity is disappointing because the response rate is around 10%, median survival about 6 months, and 1-year OS around 20%.
40#
發(fā)表于 2025-3-28 10:32:11 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-23 01:27
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
华坪县| 肃宁县| 陇南市| 鄂伦春自治旗| 江口县| 永善县| 子长县| 汤原县| 稻城县| 利津县| 大庆市| 平武县| 天台县| 松江区| 克拉玛依市| 仲巴县| 石楼县| 兰坪| 涟水县| 阿图什市| 东兴市| 锦屏县| 台湾省| 沅陵县| 甘德县| 自贡市| 怀安县| 小金县| 甘孜县| 景德镇市| 闸北区| 龙山县| 武汉市| 县级市| 彰武县| 阳原县| 青川县| 宜城市| 永吉县| 刚察县| 金山区|